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Dynamized Preparations in Cell Culture
Ellanzhiyil Surendran Sunila, Ramadasan Kuttan, Korengath Chandran Preethi and
Girija Kuttan
Amala Cancer Research Centre, Amala Nagar, Thrissur, Kerala–680 555, India
Although reports on the efficacy of homeopathic medicines in animal models are limited, there
are even fewer reports on the in vitro action of these dynamized preparations. We have
evaluated the cytotoxic activity of 30C and 200C potencies of ten dynamized medicines against
Dalton’s Lymphoma Ascites, Ehrlich’s Ascites Carcinoma, lung fibroblast (L929) and Chinese
Hamster Ovary (CHO) cell lines and compared activity with their mother tinctures during
short-term and long-term cell culture. The effect of dynamized medicines to induce apoptosis
was also evaluated and we studied how dynamized medicines affected genes expressed during
apoptosis. Mother tinctures as well as some dynamized medicines showed significant
cytotoxicity to cells during short and long-term incubation. Potentiated alcohol control did
not produce any cytotoxicity at concentrations studied. The dynamized medicines were found
to inhibit CHO cell colony formation and thymidine uptake in L929 cells and those of Thuja,
Hydrastis and Carcinosinum were found to induce apoptosis in DLA cells. Moreover,
dynamized Carcinosinum was found to induce the expression of p53 while dynamized Thuja
produced characteristic laddering pattern in agarose gel electrophoresis of DNA. These results
indicate that dynamized medicines possess cytotoxic as well as apoptosis-inducing properties.
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Introduction
Homeopathy is a system of alternative medicine that has
been practiced for more than 200 years. The homeopathic
model of treatment is based on three pillars: ‘principle of
similitude’, ‘experimentation of substances in healthy
individuals’ and ‘dynamized medicines’. For a drug to be
considered ‘homeopathic’, it should be potentiated (dyna-
mized), experienced in healthy individuals and applied
according to the principle of the similarity of symptoms.
In order to escape from the aggravation and intoxication
caused by substances used in ponderal doses, Hahnemann
started to dilute and agitate them (method of dynamiza-
tion), observing that through this process the substances
produced the same symptomatic manifestations. In this
way,adynamizedpreparationhadthesameeffectasthatof
the mother tincture and produced similar reactions in the
organisms. However, many drugs prepared in this manner
are diluted to such an extent that they go beyond
Avagadro’s number (1,2). Hence the action of homeopathic
drugs, even though clinically manifested, was always
debated in scientific community.
Recently, limited investigations on the efficacy of
dynamized medicines in animal models as well as
clinical trials have reported that potentiated Lycopodium
clavatum has protective action against CCl4-induced
liver damage in rats (3) and that chelidonium 30C
could ameliorate both p-dimethylaminoazobenzene and
azodye-induced hepatocarcinogenesis in mice (4,5). Anti-
genotoxic effect of different dynamized medicines has
also been reported (6,7): Arsenicum album was found to
ameliorate arsenic-induced toxicity in mice as well as in
clinical studies and could reduce the elevated
antinuclear antibody titer and hematological toxicities
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properly cited.(8,9). Homeopathic therapy for asymptomatic HIV
carriers has also proven beneficial (10) and recently
Rajendran (11) reported homeopathy as a supportive
therapy in cancer. Pathak et al. (12) investigated Ruta 6
on regression of human glioma brain cancer cell growth
clinically and found that Ruta induces severe telomere
erosion in MGRI brain cancer cells but has no effect on
B-lymphoid cells and normal lymphocytes. Banerji and
Banerji (13) reported that Ruta was effective for
intracranial cysticercosis.
Very few investigations have explored the action of
dynamized medicine in in vitro cell culture systems.
Podophyllum has been shown to inhibit adhesion of
neutrophils to serum-coated micro plates (14).
Traumeen S, a homeopathic formulation used clinically to
relieve trauma and inflammation has been shown to inhibit
the production of Interleukin-b, TNF-a and Interleukin-8
by human T cells and monocytes in culture (15).
Many homeopathic drugs at low potencies were found to
potentiate oxidative metabolism in cultured cells (16).
We tried to evaluate the activity of selected homeo-
pathic medicines in vitro for their cytotoxic and
apoptosis-inducing activity by cell culture methods.
Since the medications are not being used on animals
we have used the term dynamized instead of homeo-
pathic medicines (We are indebted to a referee for this
suggestion). We have also compared the effect
of dynamized medicines with that of mother tinctures.
Methods
Medicines
Our choice of medicines extensively used for cancer
treatment was suggested by renowned homeopathic
practitioner Dr Banerjee P, Kolkata, India. The dynam-
ized medicines and their mother tinctures were procured
from Willmar Schwabe, Germany.
Ethanol content in the preparations may vary and no
attempt was made to determine the exact content.
Maximum ethanol concentration used in the experiment
was 2%, which will not produce any effect on cells.
Moreover results were compared with dynamized vehicle
control or non-dynamized alcohol control.
Chemicals
Dulbecco’s Modified Eagle’s Medium (DMEM) and
Minimum Essential Medium (MEM) were purchased
from Himedia laboratories, Mumbai, India. Fetal Calf
Serum was purchased from Biological Industries, Israel.
MTT and ethidium bromide were obtained from Sigma
Aldrich, USA. Agarose was purchased from Sisco
Research Laboratories, Mumbai. Primers were purchased
from Maxim Biotech, Inc. USA. All other reagents used
were of analytical grade.
Cells
Dalton’s lymphoma ascites (DLA) and Ehrlich ascites
carcinoma (EAC) cells were originally obtained from
Cancer Institute, Adayar, Chennai and are maintained in
the peritoneal cavity of Swiss Albino mice.
L929 cells (mouse fibroblasts) and Chinese Hamster
ovary (CHO) cells were obtained from National Centre
for Cell Sciences, Pune. They were grown and maintained
in Minimum Essential Medium containing 10% fetal calf
serum.
Cytotoxicity of dynamized medicines in cells
Trypan blue exclusion method
Tumor cells were aspirated from peritoneal cavity and
pelleted by centrifugation (1000 g, for 10min). The cells
were washed with sterile phosphate-buffered saline (PBS)
and counted. They were made up at a concentration of
10 million cells per milliliter. DLA and EAC cells
(1 million cells/0.1ml) were incubated with dynamized
medicines (20ml) in a total volume of 1ml made up with
PBS. Cells were incubated at 37 C for 3h. After
incubation, 0.1ml of trypan blue (1%) was added and
cytotoxicity was determined by counting live and dead
cells using a haemocytometer. Untreated cells and cells
treated with the same volume of potentiated diluent were
used as controls.
MTT assay
L929 cells (5000 cells/well) were seeded in 96-well flat-
bottom titer plates containing 0.2ml of the medium and
allowed to adhere for 24h at 37 Ci n5 %C O 2
atmosphere. Dynamized medicines (20ml/ml) were added
and incubated for 48h. Twenty microliters of MTT
(5mg/ml) was added at 44th hour and the incubation was
continued for another 4h. After incubation plates were
centrifuged and the pelleted cells were dissolved in 0.1ml
of DMSO and optical density was measured at 570nm
Mother tincture 30C 200C
1. Thuja occidentalis ** *
2. Hydrastis canadensis ** *
3. Lycopodium clavatum ** N A
4. Conium maculatum ** *
5. Carcinosinum NA * *
6. Ruta graveolens ** *
7. Podophyllum peltatum ** *
8. Phytolacca americana ** *
9. Chelidonium majus ** *
10. Marsdenia condurango ** *
NA—not available
258 In vitro effects of dynamized medicinesusing a plate reader. Untreated cells and cells treated with
same volume of diluent were used as control.
CHO-cell colony formation
CHO cells (500 cells/plate) were plated in 25mm petridish
and incubated with Dulbecco’s Modified Eagles Medium
containing 10% FCS (5ml) in the presence and absence
of various dynamized medicines (20ml/plate) for 10 days
at 37 C in atmosphere of 5% CO2. After incubation,
plates were washed and fixed with 10% formaldehyde for
10min and stained with 1% crystal violet for 10min.
Plates were washed and the colonies were counted under
microscope. Untreated cells and cells treated with same
volume of diluent were used as control.
H
3-thymidine uptake
L929 cells (5 10
6 cells/well) were plated in 96-well flat-
bottom titer plates and incubated for 24h at 37 Ci nC O 2
atmosphere in MEM with 10% FCS. Dynamized
medicines (4ml each/well) were added and further
incubated for 24h. After that (*H
3) thymidine (1mCi)
was added and the incubation continued for another
16–18h. Then the plates were centrifuged and the
supernatant was removed. The wells were washed with
cold PBS for 3 times and 200ml of 6N NaOH was added
and incubated at 37 C for 2h. Contents were further
added into 5ml scintillation fluid and kept overnight in
dark and c.p.m. was determined using a Rack b counter
(LKB-Wallac). Untreated cells and cells treated with
same volume of diluent were used as control.
Induction of apoptosis
Mother tincture and dynamized medicines (200C and
30C) 20ml/ml were added to a MEM with 10% goat
serum (5ml) containing 1 million DLA cells/ml (suspen-
sion culture) and incubated for 48h. Further, the cells
were washed thrice with PBS, centrifuged and the pellet
was separated. A small portion of the pellet was
suspended in PBS and cell smear was prepared on a
clean glass slide and stained with haematoxylin and eosin.
Apoptosis was detected by the morphologic changes
(chromatin condensation, nuclear condensation and
formation of apoptotic bodies).
Cells were further treated with 1ml of lysis buffer
(10mM Tris–HCl, pH 8, 10mM EDTA, 0.9% NaCl,
0.2% Triton X-100) for 20min on ice and centrifuged
and at 10000r.p.m. from 10min at 4 C. Lysates were
incubated sequentially with 20mg/ml RNase at 37 C for
60min and 100mg/ml Proteinase K at 37
 
C for 3–5h
DNA was extracted with phenol–CHCl3–isoamyl alcohol
(25:24:1) and precipitated by adding 1/10th volume
of 3.5M sodium acetate pH 5.2 and equal volume of
isoamyl alcohol. DNA was placed on 1.8% agarose gel in
TBE buffer in a horizontal gel support apparatus and the
DNA ladder patterns were viewed under UV light
followed by photography.
Apoptotic gene expression—p53, Bcl-2 and caspase 3
Gene expression analysis was carried out by RT-PCR
method. Cell to cDNA
TM11 kit, Ambion Inc, USA, were
used for producing cDNA from DLA cells in culture
without isolating mRNA. DLA cells (1 10
4 cells/well)
were seeded in the 96 well ‘U’ bottom titer plate using
MEM with dynamized medicines 20 ml/ml and incubated
for 4h at 37 Ci nC O 2 atmosphere. After incubation
medium was removed and the cells were washed with ice-
cold PBS. Ice-cold cell lysis buffer 100ml were added to
the cells and immediately transferred to a water bath,
incubated for 15min at 75 C and transferred to 200 ml
holding nuclease-free micro centrifuge tubes. To this 2ml
DNase-1/100 ml cell lysis buffer were added and
incubated for 15min at 37 C. DNase was inactivated
by treating at 75 C for 5min.
PCR was performed with primers obtained from
Maxim Biotech, Inc., USA. All reagents provided in the
kit were assembled in nuclease-free micro centrifuge tube
according to the protocol of primer kit. This master
mixture (40ml) was mixed with 0.2ml Taq DNA
polymerase and 10ml cDNA sample. Reaction mixture
was vortexed and centrifuged and PCR thermal cycling
was performed according to the protocol of Maxim
Biotech, Inc. The PCR products (8ml) separated by
submerged agarose gel electrophoresis (1.8%) was visual-
ized in a UV chamber and documented with gel
documentation system.
Statistical analysis
Data was expressed as mean SD. Significance levels for
comparison of differences were determined using
Student’s t-test.
Results
Comparison of cytotoxic action of mother tincture
with dynamized medicines
DLA and EAC cells
Cytotoxicity of dynamized medicines and their mother
tinctures to DLA cells and Ehrlich cells are given in
Figs 1 and 2. Results indicated that mother tincture of
Thuja and Lycopodium was highly cytotoxic to DLA cells
and Ehrlich cells. Mother tincture of Condurango and
Hydrastis showed less effects.
It was also noted that 200C samples of Thuja
and Hydrastis showed higher cytotoxicity compared to
30C. Samples of Conium and Carcinosinum showed
eCAM 2009;6(2) 259cytotoxicity only after potentiation indicating that these
samples increased their cytotoxic potential after potentia-
tion. None of the others including diluent control had
any apparent cytotoxicity at short incubation. Results on
DLA cells and EAC cells were almost similar.
L929 cells
Most of the mother tincture showed cytotoxicity when
incubated at longer period (Fig. 3). Interestingly many of
the dynamized samples (30C and 200C) also showed
varying degrees of cytotoxicity. Conium showed 31.2%
cytotoxicity with 30C and 42.5% with 200C. Similarly
Carcinosinum showed 40.5% cytotoxicity with 30C and
39.2% with 200C. In the case of Thuja, cytotoxicity
produced at 200C was higher than 30C. Diluent control
had a cytotoxicity of only 5.7%. These results point to
the fact that many of the dynamized medicines induce
cytotoxicity to tumor cells in vitro.
CHO-cell colony formation
The effect of dynamized medicines on Chinese Hamster
cell colony formation is shown in Fig. 4. All the mother
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Figure 1. Effect of mother tincture and dynamized medicines
on Dalton’s lymphoma ascites cells. (a) Untreated Control,
(b) Potentiated diluent, (c) Thuja, (d) Hydrastis, (e) Lycopodium,
(f) Conium, (g) Carcinosinum, (h) Ruta, (i) Chelidonium,
(j) Condurango, (k) Podophyllum, (l) Phytolacca. Filled square—
Mother Tincture; Shaded square—30C; Open square—200C. *P50.01.
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Figure 2. Effect of mother tincture and dynamized medicines on Ehrlich
ascites carcinoma cells. (a) Untreated Control, (b) Potentiated
diluent, (c) Thuja, (d) Hydrastis, (e) Lycopodium, (f) Conium,
(g) Carcinosinum, (h) Ruta, (i) Chelidonium, (j) Condurango,
(k) Podophyllum, (l) Phytolacca. Filled square—Mother Tincture;
Shaded square—30C; Open square—200C. *P50.01.
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Figure 4. Effect of mother tincture and dynamized medicines on CHO
cell colony formation. (a) Untreated Control, (b) Potentiated
diluent, (c) Thuja, (d) Hydrastis, (e) Lycopodium, (f) Conium,
(g) Carcinosinum, (h) Ruta, (i) Chelidonium, (j) Condurango,
(k) Podophyllum, (l) Phytolacca. Filled square—Mother Tincture;
Shaded square—30C; Open square—200C. *P50.01.
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Figure 3. Effect of mother tincture and dynamized medicines on L929
cells. (a) Untreated Control, (b) Potentiated diluent, (c) Thuja,
(d) Hydrastis, (e) Lycopodium, (f) Conium, (g) Carcinosinum,
(h) Ruta, (i) Chelidonium, (j) Condurango, (k) Podophyllum,
(l) Phytolacca. Filled square—Mother Tincture; Shaded square—30C;
Open square—200C. *P50.01.
260 In vitro effects of dynamized medicinestinctures inhibited colony formation. Mother tinctures of
Thuja, Hydrastis, Ruta, Podophyllum and Chelidonium
showed 100% inhibition of colony formation. Conium
(61%), Lycopodium (87%), Condurango (75%) and
Phytolacca (64%) showed moderate activity.
Interestingly, 200C preparation of many dynamized
medicines also inhibited the colony formation. Thuja,
Hydrastis and Carcinosinum inhibited the colony forma-
tion by 100%, while Lycopodium (68%), Conium (82%),
Ruta (72%), Condurango (94%) and Phytolacca (62%)
showed significant activity. As in the other studies 200C
of Conium inhibited the colony formation more than
mother tincture. Diluent control did not show any
inhibition of colony formation.
Inhibition of thymidine uptake
The effect of dynamized medicines on the thymidine
uptake during L929 cell proliferation is shown in Fig. 5.
All the mother tinctures (except Phytolacca) inhibited the
thymidine uptake significantly. Inhibition of thymidine
uptake in many cases was more than 95%. Dynamized
preparation of Thuja (30C and 200C) produced nearly
43%, Hydrastis 40%, Conium produced more inhibition
at 200C. Ruta 30C produced inhibition of 50%. Other
potentiated preparations did not produce any inhibition
of thymidine uptake.
Dynamized medicines and the induction of apoptosis
Morphology and DNA laddering
The effect of dynamized medicines on induction of
apoptosis is given in Table 1. Results indicate that most
of the mother tinctures as well as some potentiated
preparations induced apoptosis as seen by their morphol-
ogical features. DNA isolated from cells treated with
potentiated preparations produced typical DNA ladder-
ing after electrophoresis indicating the presence of
apoptotic cells (Fig. 6).
Expression of apoptotic genes
The expression of proapoptotic genes p53, Caspase 3 and
antiapoptotic gene Bcl-2 was checked with Ruta 200C,
Thuja 200C and Carcinosinum 200C. Although there was
no expression of p53 and Caspase 3 when incubated with
Ruta and Thuja, Carcinosinum induced significant
Figure 6. Effect of mother tincture and dynamized medicines on DNA
laddering. Lane 1: Control. Lane 2: Hydrastis MT. Lane 3: Hydrastis
30C. Lane 4: Hydrastis 200C. Lane 5: Lycopodium MT. Lane6:
Lycopodium 30C. Lane 7: Conium MT. Lane 8: Conium 30C. Lane 9:
Conium 200C. Lane10: Thuja MT. Lane11: Thuja 30C. Lane12: Thuja
200C. Lane13: Chelidonium MT. Lane14: Chelidonium 30C. Lane15:
Chelidonium 200C. Lane16: Ruta MT. Lane17: Ruta 30C. Lane18:
Ruta200C.
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Figure 5. Effect of mother tincture and dynamized medicines
on thymidine uptake. (a) Untreated Control, (b) Potentiated diluent,
(c) Thuja, (d) Hydrastis, (e) Lycopodium, (f) Conium,
(g) Carcinosinum, (h) Ruta, (i) Chelidonium, (j) Condurango,
(k) Podophyllum, (l) Phytolacca. Filled square—Mother Tincture;
Shaded square—30C; Open square—200C. *P50.01.
Table 1. Induction of apoptosis by mother tincture and dynamized
medicines
Induction of apoptosis
Dynamized medicines (20ml/ml) MT 30C 200C
Thuja þþþ
Hydrastis þþ 
Conium    
Lycopodium þþND
Carcinosinum ND þþ
Ruta þ þ
Chelidonium þ  
Condurango þ ND  
Podophyllum þ  
Phytolacca þ  
Diluent control did not produced any apoptosis.
MT, mother tincture; ND, not determined.
eCAM 2009;6(2) 261expression of p53, which is a proapoptotic gene (Fig. 7).
Bcl-2 gene (anti-apoptotic) was not expressed by any of
the drug treatment while internal control GAPDH was
expressed in all the samples.
Discussion
Although the healing potential of homeopathic drugs is
widely accepted, the exact mechanism of action is still
unclear. In paragraphs 63–69 of Organon, Hahneman
describes the mechanism of action through the ‘primary
action’ of the medicine (dynamized or not) and the
‘secondary and curative reaction’ of the organism: ‘Every
agent that acts upon the vitality, every medicine, deranges
more or less the vital force, and causes a certain
alteration in the health of the individual for a longer or
a shorter period. This is termed primary action. Although
a product of the medicinal and vital powers conjointly, it
is principally due to the former power. To its action our
vital force endeavors to oppose its own energy. This
resistant action is a property, is indeed an automatic
action of our life-preserving power, which goes by the
name of secondary action or counteraction’. We have
tried to explain the mechanism of action of the
dynamized preparations taking into consideration the
original proposition by Samuel Hahnemann and have
approached this problem by investigating the action of
dynamized drugs in various cultured cells in a systematic
scientific manner.
Cytotoxic activity of a drug is often considered a first step
towardselucidatingitspossibleuseagainstcancerandallof
the drugs selected are being used by homeopathic prac-
tioners against cancer. We found that in short-term
cytotoxicity research, some of the dynamized preparations
showedsignificantcytotoxicactionsagainstcancercelllines
and at times the activity was higher than that of the mother
tinctures. For example, Conium at 200C potency was more
cytotoxic than its mother tincture and that the cytotoxicity
induced by Carcinosinum was higher at 200C than at 30C
potency indicating that dynamization induces the cytotoxic
potential of these medications. Results were more pro-
nounced during MTT assay in which a longer period of
incubation was involved. Many dynamized preparations at
potency of 200C inhibited the growth of L929 cells.
Clonogenic assay using CHO cells is a standard method
to determine growth inhibitory activity of the drugs and we
found that dynamized preparations of Thuja, Hydrastis,
Carcinosinum and Podophyllum at 200C potency almost
completely inhibited the CHO colony formation. As in
other cases, Conium 200C was more active than 30C.
We have confirmed the cytotoxic potential of dynamized
preparations by thymidine uptake, for the marker of the
inhibition DNAsynthesis.Asinthe caseotherexperiments,
DNA synthesis was significantly inhibited by several
dynamized preparations.
Cytotoxicity could be produced in cells either by
necrosis or by apoptotic induction. Apoptosis, which is
known as programmed cell death is highly regulated by
events taking place within the cell and is highly relevant
with respect to the destruction and removal of trans-
formed cells from the body. The induction of apoptosis
could be an external agent and a cascade of reactions
taking place within the cell produces an ultimate cell
death. Some of the events via occurring during apoptosis
include morphological changes in the cell, production of
apoptotic bodies, damage to genetic material and finally
induction of proteolytic enzymes, which produces cellular
destruction. Apoptosis could be visualized by morphol-
ogy and DNA laddering. In the present study, dynamized
preparations induced apoptosis as observed from their
morphology and DNA laddering. Moreover, dynamized
preparation of Carcinosinum could induce the p53, which
is considered to be a proapoptotic protein and involved
in signal transduction pathway.
The mechanism of action of some of the homeopathic
drugs has been proposed. Potentiated preparation of Ruta
possesses protective action on normal B-lymphoid cells
against H2O2-induced chromosomal damage (13).
Moreover, the telomere erosion was enhanced in cancer
cells by treatment with Ruta while normal cells showed no
change. Thus, the telomeres that protect individual
chromosomes of cancer cells are damaged by Ruta, which
Figure 7. Effect of dynamized medicines on p53 expression. Lane 1:
Positive control. Lane 2: Untreated control. Lane 3: Succussed alcohol
control. Lane 4: Thuja 200C. Lane 5: Ruta 200C. Lane 6: Carcinosinum
200C. Lane 7: GADPH. Lane 8: Mol. Wt markers.
262 In vitro effects of dynamized medicinesmay be the mechanism of its therapeutic action in brain
cancer (13).
The protective effect of Chelidonium against p-DAB-
induced hepatic cancer may occur by the modulating
effect of the drug on restoration of damage caused to
several gene-regulated phenomena like enzyme activities
and chromosomal abnormalities. This gives insight into
the mechanism of action, which may be by means of
interfering with the process of carcinogenesis by actively
modifying actions of oncogenes or by activating tumor
suppressor genes (5). Another mechanism of actions of
homeopathic drugs may occur through immune modifi-
cation. Benveniste (17) has shown that human basophils
undergo degranulation not only at usual anti-IgE anti-
body doses but also at extremely high dilutions. Bastide
(18)has shown the therapeutic effect of high dilution of
a–b interferon and thymic hormones on cellular immu-
nity and had good therapeutic effect in immunodepressed
patients. Similarly Bentwich et al. (19) revealed that
small amounts of antigens are capable of specific
antibody response. The role of immunity in the ther-
apeutic efficacy of homeopathic medicines has also been
reviewed (20).
Our results indicate that the dynamized preparation
initially produces a secondary action on cells that is in
line with the original proposition by Hahnemann on the
mechanism of action of medicines dynamized or not.
However, our limited knowledge in this area does not
fully explain the mechanism of action of all drugs that
we investigated. More scientific analyses are warranted
to elucidate these interesting preparations of ultra
dilutions.
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